Literature DB >> 30166462

Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.

Nathaniel D Anderson1,2, Richard de Borja1, Matthew D Young3, Fabio Fuligni1, Andrej Rosic1, Nicola D Roberts3, Simon Hajjar1, Mehdi Layeghifard1, Ana Novokmet1, Paul E Kowalski1, Matthew Anaka1, Scott Davidson4, Mehdi Zarrei5, Badr Id Said1, L Christine Schreiner1, Remi Marchand1, Joseph Sitter1, Nalan Gokgoz6, Ledia Brunga1, Garrett T Graham7, Anthony Fullam3, Nischalan Pillay8,9, Jeffrey A Toretsky7, Akihiko Yoshida10, Tatsuhiro Shibata11,12, Markus Metzler13, Gino R Somers2,14, Stephen W Scherer1,5,15,16, Adrienne M Flanagan9,10, Peter J Campbell3,17, Joshua D Schiffman18, Mary Shago2,4, Ludmil B Alexandrov19, Jay S Wunder20,21, Irene L Andrulis6,15, David Malkin22,23,24, Sam Behjati25,26, Adam Shlien22,2,4.   

Abstract

Sarcomas are cancers of the bone and soft tissue often defined by gene fusions. Ewing sarcoma involves fusions between EWSR1, a gene encoding an RNA binding protein, and E26 transformation-specific (ETS) transcription factors. We explored how and when EWSR1-ETS fusions arise by studying the whole genomes of Ewing sarcomas. In 52 of 124 (42%) of tumors, the fusion gene arises by a sudden burst of complex, loop-like rearrangements, a process called chromoplexy, rather than by simple reciprocal translocations. These loops always contained the disease-defining fusion at the center, but they disrupted multiple additional genes. The loops occurred preferentially in early replicating and transcriptionally active genomic regions. Similar loops forming canonical fusions were found in three other sarcoma types. Chromoplexy-generated fusions appear to be associated with an aggressive form of Ewing sarcoma. These loops arise early, giving rise to both primary and relapse Ewing sarcoma tumors, which can continue to evolve in parallel.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30166462      PMCID: PMC6176908          DOI: 10.1126/science.aam8419

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  43 in total

1.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 2.  Criteria for inference of chromothripsis in cancer genomes.

Authors:  Jan O Korbel; Peter J Campbell
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

Review 3.  Toward better understanding of artifacts in variant calling from high-coverage samples.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2014-06-27       Impact factor: 6.937

4.  RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.

Authors:  Elli Papaemmanuil; Inmaculada Rapado; Yilong Li; Nicola E Potter; David C Wedge; Jose Tubio; Ludmil B Alexandrov; Peter Van Loo; Susanna L Cooke; John Marshall; Inigo Martincorena; Jonathan Hinton; Gunes Gundem; Frederik W van Delft; Serena Nik-Zainal; David R Jones; Manasa Ramakrishna; Ian Titley; Lucy Stebbings; Catherine Leroy; Andrew Menzies; John Gamble; Ben Robinson; Laura Mudie; Keiran Raine; Sarah O'Meara; Jon W Teague; Adam P Butler; Giovanni Cazzaniga; Andrea Biondi; Jan Zuna; Helena Kempski; Markus Muschen; Anthony M Ford; Michael R Stratton; Mel Greaves; Peter J Campbell
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

5.  The Molecular Signatures Database (MSigDB) hallmark gene set collection.

Authors:  Arthur Liberzon; Chet Birger; Helga Thorvaldsdóttir; Mahmoud Ghandi; Jill P Mesirov; Pablo Tamayo
Journal:  Cell Syst       Date:  2015-12-23       Impact factor: 10.304

Review 6.  The impact of translocations and gene fusions on cancer causation.

Authors:  Felix Mitelman; Bertil Johansson; Fredrik Mertens
Journal:  Nat Rev Cancer       Date:  2007-03-15       Impact factor: 60.716

7.  Massive genomic rearrangement acquired in a single catastrophic event during cancer development.

Authors:  Philip J Stephens; Chris D Greenman; Beiyuan Fu; Fengtang Yang; Graham R Bignell; Laura J Mudie; Erin D Pleasance; King Wai Lau; David Beare; Lucy A Stebbings; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Michael A Quail; John Burton; Harold Swerdlow; Nigel P Carter; Laura A Morsberger; Christine Iacobuzio-Donahue; George A Follows; Anthony R Green; Adrienne M Flanagan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

10.  A somatic reference standard for cancer genome sequencing.

Authors:  David W Craig; Sara Nasser; Richard Corbett; Simon K Chan; Lisa Murray; Christophe Legendre; Waibhav Tembe; Jonathan Adkins; Nancy Kim; Shukmei Wong; Angela Baker; Daniel Enriquez; Stephanie Pond; Erin Pleasance; Andrew J Mungall; Richard A Moore; Timothy McDaniel; Yussanne Ma; Steven J M Jones; Marco A Marra; John D Carpten; Winnie S Liang
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

View more
  47 in total

1.  The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.

Authors:  Yusuke Tsuda; Lei Zhang; Paul Meyers; William D Tap; John H Healey; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2020-05-28       Impact factor: 5.006

Review 2.  TP53 in bone and soft tissue sarcomas.

Authors:  Elizabeth Thoenen; Amanda Curl; Tomoo Iwakuma
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

Review 3.  The genomic landscape of pediatric cancers: Implications for diagnosis and treatment.

Authors:  E Alejandro Sweet-Cordero; Jaclyn A Biegel
Journal:  Science       Date:  2019-03-15       Impact factor: 47.728

Review 4.  The Iceberg under Water: Unexplored Complexity of Chromoanagenesis in Congenital Disorders.

Authors:  Cinthya J Zepeda-Mendoza; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2019-04-04       Impact factor: 11.025

Review 5.  Computational analysis of cancer genome sequencing data.

Authors:  Isidro Cortés-Ciriano; Doga C Gulhan; Jake June-Koo Lee; Giorgio E M Melloni; Peter J Park
Journal:  Nat Rev Genet       Date:  2021-12-08       Impact factor: 53.242

6.  Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression.

Authors:  Célia Dupain; Céline Gracia; Anne C Harttrampf; Julie Rivière; Birgit Geoerger; Liliane Massaad-Massade
Journal:  Oncogene       Date:  2019-09-05       Impact factor: 9.867

7.  The mutational landscape of normal human endometrial epithelium.

Authors:  Luiza Moore; Daniel Leongamornlert; Tim H H Coorens; Mathijs A Sanders; Peter Ellis; Stefan C Dentro; Kevin J Dawson; Tim Butler; Raheleh Rahbari; Thomas J Mitchell; Francesco Maura; Jyoti Nangalia; Patrick S Tarpey; Simon F Brunner; Henry Lee-Six; Yvette Hooks; Sarah Moody; Krishnaa T Mahbubani; Mercedes Jimenez-Linan; Jan J Brosens; Christine A Iacobuzio-Donahue; Inigo Martincorena; Kourosh Saeb-Parsy; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2020-04-22       Impact factor: 49.962

Review 8.  Mechanistic origins of diverse genome rearrangements in cancer.

Authors:  Rashmi Dahiya; Qing Hu; Peter Ly
Journal:  Semin Cell Dev Biol       Date:  2021-04-03       Impact factor: 7.727

9.  Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells.

Authors:  Didier Surdez; Erika Brunet; Anna Sole; Sandrine Grossetête; Maxime Heintzé; Loelia Babin; Sakina Zaïdi; Patrick Revy; Benjamin Renouf; Anne De Cian; Carine Giovannangeli; Cécile Pierre-Eugène; Isabelle Janoueix-Lerosey; Lucile Couronné; Sophie Kaltenbach; Mark Tomishima; Maria Jasin; Thomas G P Grünewald; Olivier Delattre
Journal:  Cancer Res       Date:  2021-08-02       Impact factor: 12.701

10.  A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas.

Authors:  Avanthi Tayi Shah; Tej D Azad; Marcus R Breese; Jacob J Chabon; Emily G Hamilton; Krystal Straessler; David M Kurtz; Stanley G Leung; Aviv Spillinger; Heng-Yi Liu; Inge H Behroozfard; Frederick M Wittber; Florette K Hazard; Soo-Jin Cho; Heike E Daldrup-Link; Kieuhoa T Vo; Arun Rangaswami; Allison Pribnow; Sheri L Spunt; Norman J Lacayo; Maximilian Diehn; Ash A Alizadeh; E Alejandro Sweet-Cordero
Journal:  Mol Cancer Ther       Date:  2021-08-05       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.